Navigation Links
NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
Date:11/4/2011

DURHAM, N.C., Nov. 4, 2011 /PRNewswire/ -- NeuroCog Trials, Inc. today announced the appointment of Michael R. Hufford, Ph.D. to the position of Chief Operating Officer.  In this newly created position, Dr. Hufford will assume responsibility for the continued growth and expansion of NeuroCog Trials' business, research and development, and operations.

"The investment in research and development for pro-cognitive therapies across a wide variety of therapeutic areas has never been stronger.  As NeuroCog Trials continues to grow to meet these needs, we decided that it was time to bring someone on board with a proven track record of success on both the vendor and sponsor side of clinical research," said Richard Keefe, Ph.D., Founder and Chief Executive Officer at NeuroCog Trials. "We are delighted to have Dr. Hufford bring the wealth of his experience in industry, academia and entrepreneurship to NeuroCog Trials.  His role at NeuroCog represents a real advance for us in our ability to provide key services for increasingly larger trials across a broad range of CNS and other therapeutic areas."

Dr. Hufford brings to the company more than 14 years of experience in clinical research and drug development.  Prior to joining NeuroCog Trials, he was Vice President of Clinical Development at Cypress Bioscience, where he was responsible for drug and medical device development for multiple CNS programs.  Before joining Cypress, he worked at Amylin Pharmaceuticals, leading drug development teams focused on orphan drug development for rare metabolic diseases, combination peptide and protein therapies for obesity, and helped to spinout and was on the board of Psylin Neurosciences.  Between 2000 and 2005, Dr. Hufford was Vice President of Scientific Affairs at invivodata, inc., an electronic patient-reported outcomes company.  Prior to that, he was an Assistant Professor of Clinical Psychology at the University of Montana.  
'/>"/>

SOURCE NeuroCog Trials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Data From REMEDEE Trial Featuring OrbusNeichs Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
2. CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
3. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
4. Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement
5. Middle East to be the Future in Clincial Trials
6. Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule Revamilast
7. Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
8. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
9. Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International
10. ERA-EDTA Congress 2011: Late Breaking Clinical Trials I
11. ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardts Disease and Dry Age-Related Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015   Inocucor Technologies Inc ., the ... for farmers, has received a notice of allowance ... its patent application to protect Inocucor consortia and ... enhance yields on farms and in greenhouses. ... IN-M1 microbial consortium and its fermentation byproducts, which ...
(Date:7/27/2015)... ... July 27, 2015 , ... BlueInGreen® ... Monday. The venture will bring the world’s most efficient gas dissolution technology to ... and technologies to both the industrial and municipal markets. With offices located in ...
(Date:7/27/2015)... July 27, 2015 The Brain ... winners of its annual Klerman and Freedman Prizes, ... who have been supported by NARSAD Young Investigator ... pursue innovative ideas in neurobiological and psychosocial research, ... for the early detection, treatment, prevention and cure ...
(Date:7/27/2015)... -- IDEXX Laboratories, Inc. (NASDAQ: IDXX ) announced ... 100,000 specimens to IDEXX Reference Laboratories for symmetric dimethylarginine, ... since the breakthrough kidney function test launched in the ... of suffering and death in cats and dogs. The ... accepted kidney disease prevalence data showing that 1 in ...
Breaking Biology Technology:Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 2Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 3BlueInGreen Brings Water Treatment Technology to Florida 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5
... LLC (, http://www.CJPS-Enterprises.com ) announced that it ... services to leverage companies, intellectual property (IP) to ... of their intangible assets.,This customized service is execution-driven, ... a firm that specializes in growing,companies in the ...
... ... Prostate Surgery, SAN DIEGO, Nov. ... InnerCool Therapies, Inc., today,announced that it has developed a pelvic cooling ... surgery,for prostate cancer (radical prostatectomy). The new technology is being,applied in ...
... Vitamin E May Help,Prevent, Cardiovascular Events in Hp2-2 ... (Amex: SYI ) today announced new data demonstrating ... Diabetes may result,in an increased risk of heart attack ... today at the Annual Scientific,Sessions of the American Heart ...
Cached Biology Technology:CJPS Enterprises Provides New Strategies To Create Additional Revenues for Companies with Intellectual Property 2Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 2Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 3Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 4Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 5Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 6Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 7Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 8Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting 2Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting 3Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting 4
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... the addition of the "Next Generation Biometrics Market ... to 2020" report to their offering. ... $24.4 Billion by 2020, at a CAGR of 17.9% ... is the leading application for the market. Safran ...
(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
... Mount Sinai School of Medicine have found in a ... Mount Sinai stabilized or improved cardiac function in people ... of the therapy, called SERCA2a, experienced substantial clinical benefit ... need in this population. The data are published online ...
... Some areas of the southern United States are suffering from ... University study shows that could prove problematic for aquatic organisms. ... some chemicals in the environment more toxic to fish and ... exacerbate the magnitudes of the natural pH shifts in the ...
... seawater algae could hold the key to crops as a ... climates. Researchers at the University of Edinburgh have found ... its main food source is in short supply. Understanding ... when nutrients are scarce and to grow high-yield plants for ...
Cached Biology News:Mount Sinai researchers develop new gene therapy for heart failure 2Study shows climate change makes some chemicals more toxic to aquatic life 2
... The dual-bay DNA Engine Dyad ... for DNA amplification (PCR). The chassis ... units (sample-holder, heat-pump assemblies), which hold ... Color display offers graphical programming with ...
... Red fluorescent RNA stain is used to ... or glyoxal) agarose gels and does not ... a 302 nm transilluminator, the stain emits ... on Polaroid film or with a CCD ...
... The MitoPT kit is used in conjunction ... in culture and induce apoptosis according to your ... cells as a negative control). Once you have ... MitoPT solution to each population and incubate the ...
... Disruption of the mitochondrial transmembrane ... intracellular events that occur following induction ... Detection Kit utilizes a lipophilic cation, ... activity marker. MitoLight is a mitochondrial ...
Biology Products: